ReP USP - Resultado da busca

Artigo de periodico
Test systems for voltage stability studies (2020)
Van Cutsem, Thierry; Glavic, Mevludin; Rosehart, William; Canizares, Claudio; Kanatas, Mario; Lima, Leonardo; Milano, Federico; Papangelis, Lampros; Ramos, Rodrigo Andrade ; Santos, Jhonatan Andrade dos; Tamimi, Behnam; Taranto, Glauco; Vournas, Costas
Source: IEEE Transactions on Power Systems. Unidade: EESC
Subjects: POTENCIAL ELÉTRICO, ENGENHARIA ELÉTRICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
VAN CUTSEM, Thierry et al. Test systems for voltage stability studies. IEEE Transactions on Power Systems, v. 35, n. 5, p. Se 2020, 2020Tradução . . Disponível em: http://dx.doi.org/10.1109/TPWRS.2020.2976834. Acesso em: 15 nov. 2024.
APA
Van Cutsem, T., Glavic, M., Rosehart, W., Canizares, C., Kanatas, M., Lima, L., et al. (2020). Test systems for voltage stability studies. IEEE Transactions on Power Systems, 35( 5), Se 2020. doi:10.1109/TPWRS.2020.2976834
NLM
Van Cutsem T, Glavic M, Rosehart W, Canizares C, Kanatas M, Lima L, Milano F, Papangelis L, Ramos RA, Santos JA dos, Tamimi B, Taranto G, Vournas C. Test systems for voltage stability studies [Internet]. IEEE Transactions on Power Systems. 2020 ; 35( 5): Se 2020.[citado 2024 nov. 15 ] Available from: http://dx.doi.org/10.1109/TPWRS.2020.2976834
Vancouver
Van Cutsem T, Glavic M, Rosehart W, Canizares C, Kanatas M, Lima L, Milano F, Papangelis L, Ramos RA, Santos JA dos, Tamimi B, Taranto G, Vournas C. Test systems for voltage stability studies [Internet]. IEEE Transactions on Power Systems. 2020 ; 35( 5): Se 2020.[citado 2024 nov. 15 ] Available from: http://dx.doi.org/10.1109/TPWRS.2020.2976834
Artigo de periodico
Complement C3 vs C5 inhibition in severe COVID-19: early clinical findings reveal differential biological efficacy (2020)
Mastellos, Dimitrios C.; Silva, Bruno Garcia Peixoto Pires da; Fonseca, Benedito Antonio Lopes da; Fonseca, Natasha Peixoto; Martins, Maria Auxiliadora; Mastaglio, Sara; Ruggeri, Annalisa; Sironi, Marina; Radermacher, Peter; Chrysanthopoulou, Akrivi; Skendros, Panagiotis; Ritis, Konstantinos; Manfra, Ilenia; Iacobelli, Simona; Huber-Lang, Markus; Nilsson, Bo; Yancopoulou, Despina; Connolly, E. Sander; Garlanda, Cecilia; Ciceri, Fabio; Risitano, Antonio M.; Calado, Rodrigo Tocantins; Lambris, John D.
Source: Clinical Immunology. Unidade: FMRP
Subjects: COVID-19, TROMBOSE, FÁRMACOS, BIOMARCADORES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MASTELLOS, Dimitrios C. et al. Complement C3 vs C5 inhibition in severe COVID-19: early clinical findings reveal differential biological efficacy. Clinical Immunology, v. 220, 2020Tradução . . Disponível em: https://doi.org/10.1016/j.clim.2020.108598. Acesso em: 15 nov. 2024.
APA
Mastellos, D. C., Silva, B. G. P. P. da, Fonseca, B. A. L. da, Fonseca, N. P., Martins, M. A., Mastaglio, S., et al. (2020). Complement C3 vs C5 inhibition in severe COVID-19: early clinical findings reveal differential biological efficacy. Clinical Immunology, 220. doi:10.1016/j.clim.2020.108598
NLM
Mastellos DC, Silva BGPP da, Fonseca BAL da, Fonseca NP, Martins MA, Mastaglio S, Ruggeri A, Sironi M, Radermacher P, Chrysanthopoulou A, Skendros P, Ritis K, Manfra I, Iacobelli S, Huber-Lang M, Nilsson B, Yancopoulou D, Connolly ES, Garlanda C, Ciceri F, Risitano AM, Calado RT, Lambris JD. Complement C3 vs C5 inhibition in severe COVID-19: early clinical findings reveal differential biological efficacy [Internet]. Clinical Immunology. 2020 ; 220[citado 2024 nov. 15 ] Available from: https://doi.org/10.1016/j.clim.2020.108598
Vancouver
Mastellos DC, Silva BGPP da, Fonseca BAL da, Fonseca NP, Martins MA, Mastaglio S, Ruggeri A, Sironi M, Radermacher P, Chrysanthopoulou A, Skendros P, Ritis K, Manfra I, Iacobelli S, Huber-Lang M, Nilsson B, Yancopoulou D, Connolly ES, Garlanda C, Ciceri F, Risitano AM, Calado RT, Lambris JD. Complement C3 vs C5 inhibition in severe COVID-19: early clinical findings reveal differential biological efficacy [Internet]. Clinical Immunology. 2020 ; 220[citado 2024 nov. 15 ] Available from: https://doi.org/10.1016/j.clim.2020.108598
Artigo de periodico
Comparative genomics reveals high biological diversity and specific adaptations in the industrially and medically important fungal genus Aspergillus (2017)
Vries, Ronald P. de; Riley, Robert; Wiebenga, Ad; Aguilar-Osorio, Guillermo; Amillis, Sotiris; Uchima, Cristiane Akemi; Anderluh, Gregor; Asadollahi, Mojtaba; Askin, Marion; Barry, Kerrie; Goldman, Gustavo Henrique
Source: Genome Biology. Unidade: FCFRP
Subjects: ASPERGILLUS, GENOMAS, METILAÇÃO DE DNA, FILOGENIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
VRIES, Ronald P. de et al. Comparative genomics reveals high biological diversity and specific adaptations in the industrially and medically important fungal genus Aspergillus. Genome Biology, v. 18, n. 1, 2017Tradução . . Disponível em: https://doi.org/10.1186/s13059-017-1151-0. Acesso em: 15 nov. 2024.
APA
Vries, R. P. de, Riley, R., Wiebenga, A., Aguilar-Osorio, G., Amillis, S., Uchima, C. A., et al. (2017). Comparative genomics reveals high biological diversity and specific adaptations in the industrially and medically important fungal genus Aspergillus. Genome Biology, 18( 1). doi:10.1186/s13059-017-1151-0
NLM
Vries RP de, Riley R, Wiebenga A, Aguilar-Osorio G, Amillis S, Uchima CA, Anderluh G, Asadollahi M, Askin M, Barry K, Goldman GH. Comparative genomics reveals high biological diversity and specific adaptations in the industrially and medically important fungal genus Aspergillus [Internet]. Genome Biology. 2017 ; 18( 1):[citado 2024 nov. 15 ] Available from: https://doi.org/10.1186/s13059-017-1151-0
Vancouver
Vries RP de, Riley R, Wiebenga A, Aguilar-Osorio G, Amillis S, Uchima CA, Anderluh G, Asadollahi M, Askin M, Barry K, Goldman GH. Comparative genomics reveals high biological diversity and specific adaptations in the industrially and medically important fungal genus Aspergillus [Internet]. Genome Biology. 2017 ; 18( 1):[citado 2024 nov. 15 ] Available from: https://doi.org/10.1186/s13059-017-1151-0
Artigo de periodico
Diagnostic accuracy of a clinical diagnosis of idiopathic pulmonary fibrosis: an international case–cohort study (2017)
Walsh, Simon L. F.; Maher, Toby M.; Kolb, Martin; Poletti, Venerino; Nusser, Richard; Richeldi, Luca; Vancheri, Carlo; Wilsher, Margaret L.; Antoniou, Katerina M.; Behr, Jüergen; Bendstrup, Elisabeth; Brown, Kevin; Calandriello, Lucio; Corte, Tamera J.; Cottin, Vincent; Crestani, Bruno; Flaherty, Kevin; Glaspole, Ian; Grutters, Jan; Inoue, Yoshikazu; Kokosi, Maria; Kondoh, Yasuhiro; Kouranos, Vasileios; Kreuter, Michael; Johannson, Kerri; Judge, Eoin; Ley, Brett; Margaritopoulos, George; Martinez, Fernando J.; Molina-Molina, Maria; Morais, António; Nunes, Hilario; Raghu, Ganesh; Ryerson, Christopher J.; Selman, Moises; Spagnolo, Paolo; Taniguchi, Hiroyuki; Tomassetti, Sara; Valeyre, Dominique; Wijsenbeek, Marlies; Wuyts, Wim; Hansell, David; Wells, Athol; Fabro, Alexandre Todorovic
Source: European Respiratory Journal. Unidade: FMRP
Subjects: DIAGNÓSTICO DIFERENCIAL, PROGNÓSTICO, REPRODUTIBILIDADE DE RESULTADOS, FIBROSE PULMONAR, COOPERAÇÃO INTERNACIONAL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
WALSH, Simon L. F. et al. Diagnostic accuracy of a clinical diagnosis of idiopathic pulmonary fibrosis: an international case–cohort study. European Respiratory Journal, v. 50, n. 2, 2017Tradução . . Disponível em: https://doi.org/10.1183/13993003.00936-2017. Acesso em: 15 nov. 2024.
APA
Walsh, S. L. F., Maher, T. M., Kolb, M., Poletti, V., Nusser, R., Richeldi, L., et al. (2017). Diagnostic accuracy of a clinical diagnosis of idiopathic pulmonary fibrosis: an international case–cohort study. European Respiratory Journal, 50( 2). doi:10.1183/13993003.00936-2017
NLM
Walsh SLF, Maher TM, Kolb M, Poletti V, Nusser R, Richeldi L, Vancheri C, Wilsher ML, Antoniou KM, Behr J, Bendstrup E, Brown K, Calandriello L, Corte TJ, Cottin V, Crestani B, Flaherty K, Glaspole I, Grutters J, Inoue Y, Kokosi M, Kondoh Y, Kouranos V, Kreuter M, Johannson K, Judge E, Ley B, Margaritopoulos G, Martinez FJ, Molina-Molina M, Morais A, Nunes H, Raghu G, Ryerson CJ, Selman M, Spagnolo P, Taniguchi H, Tomassetti S, Valeyre D, Wijsenbeek M, Wuyts W, Hansell D, Wells A, Fabro AT. Diagnostic accuracy of a clinical diagnosis of idiopathic pulmonary fibrosis: an international case–cohort study [Internet]. European Respiratory Journal. 2017 ; 50( 2):[citado 2024 nov. 15 ] Available from: https://doi.org/10.1183/13993003.00936-2017
Vancouver
Walsh SLF, Maher TM, Kolb M, Poletti V, Nusser R, Richeldi L, Vancheri C, Wilsher ML, Antoniou KM, Behr J, Bendstrup E, Brown K, Calandriello L, Corte TJ, Cottin V, Crestani B, Flaherty K, Glaspole I, Grutters J, Inoue Y, Kokosi M, Kondoh Y, Kouranos V, Kreuter M, Johannson K, Judge E, Ley B, Margaritopoulos G, Martinez FJ, Molina-Molina M, Morais A, Nunes H, Raghu G, Ryerson CJ, Selman M, Spagnolo P, Taniguchi H, Tomassetti S, Valeyre D, Wijsenbeek M, Wuyts W, Hansell D, Wells A, Fabro AT. Diagnostic accuracy of a clinical diagnosis of idiopathic pulmonary fibrosis: an international case–cohort study [Internet]. European Respiratory Journal. 2017 ; 50( 2):[citado 2024 nov. 15 ] Available from: https://doi.org/10.1183/13993003.00936-2017
Artigo de periodico
Does ex vivo CD34+ positive selection influence outcome after autologous hematopoietic stem cell transplantation in systemic sclerosis patients? (2016)
Rodrigues, Maria Carolina de Oliveira; Labopin, M; Henes, J; Moore, J; Papa, N. D; Cras, A; Sakellari, I; Schroers, R; Scherer, H. U; Cuneo, A; Kyrcz-Krzemien, S; Daikeler, T; Alexander, T; Finke, J; Badoglio, M; Simões, Belinda Pinto; Snowden, J A; Farge, D
Source: Bone Marrow Transplantation. Unidade: FMRP
Subjects: DOENÇAS AUTOIMUNES, SOBREVIVÊNCIA LIVRE DE DOENÇA, CÉLULAS-TRONCO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
RODRIGUES, Maria Carolina de Oliveira et al. Does ex vivo CD34+ positive selection influence outcome after autologous hematopoietic stem cell transplantation in systemic sclerosis patients?. Bone Marrow Transplantation, v. 51, n. 4, p. 501-505, 2016Tradução . . Disponível em: https://doi.org/10.1038/bmt.2015.299. Acesso em: 15 nov. 2024.
APA
Rodrigues, M. C. de O., Labopin, M., Henes, J., Moore, J., Papa, N. D., Cras, A., et al. (2016). Does ex vivo CD34+ positive selection influence outcome after autologous hematopoietic stem cell transplantation in systemic sclerosis patients? Bone Marrow Transplantation, 51( 4), 501-505. doi:10.1038/bmt.2015.299
NLM
Rodrigues MC de O, Labopin M, Henes J, Moore J, Papa ND, Cras A, Sakellari I, Schroers R, Scherer HU, Cuneo A, Kyrcz-Krzemien S, Daikeler T, Alexander T, Finke J, Badoglio M, Simões BP, Snowden JA, Farge D. Does ex vivo CD34+ positive selection influence outcome after autologous hematopoietic stem cell transplantation in systemic sclerosis patients? [Internet]. Bone Marrow Transplantation. 2016 ; 51( 4): 501-505.[citado 2024 nov. 15 ] Available from: https://doi.org/10.1038/bmt.2015.299
Vancouver
Rodrigues MC de O, Labopin M, Henes J, Moore J, Papa ND, Cras A, Sakellari I, Schroers R, Scherer HU, Cuneo A, Kyrcz-Krzemien S, Daikeler T, Alexander T, Finke J, Badoglio M, Simões BP, Snowden JA, Farge D. Does ex vivo CD34+ positive selection influence outcome after autologous hematopoietic stem cell transplantation in systemic sclerosis patients? [Internet]. Bone Marrow Transplantation. 2016 ; 51( 4): 501-505.[citado 2024 nov. 15 ] Available from: https://doi.org/10.1038/bmt.2015.299

USP Schools

ReP

Filtros

Authors

USP affiliated authors

Subjects

Indexado em

Non normalized affiliation

Countries of institutions of collaboration